BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29713764)

  • 1. Novel use of
    Parihar AS; Sood A; Kumar R; Bhusari P; Shukla J; Mittal BR
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1836-1837. PubMed ID: 29713764
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholecystokinin 2 Receptor Agonist
    Rottenburger C; Nicolas GP; McDougall L; Kaul F; Cachovan M; Vija AH; Schibli R; Geistlich S; Schumann A; Rau T; Glatz K; Behe M; Christ ER; Wild D
    J Nucl Med; 2020 Apr; 61(4):520-526. PubMed ID: 31519804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of 68Ga-DOTA-RGD (αvβ3) PET/CT Imaging in Thyroglobulin Elevation With Negative Iodine Scintigraphy.
    Vatsa R; Shykla J; Mittal BR; Bhusari P; Sood A; Basher RK; Bhattacharya A
    Clin Nucl Med; 2017 Jun; 42(6):471-472. PubMed ID: 28346249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
    Persson M; Rasmussen P; Madsen J; Ploug M; Kjaer A
    Nucl Med Biol; 2012 Oct; 39(7):962-9. PubMed ID: 22739362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False positive and false negative thyroid 99mTc-sestamibi scintigraphy in the same patient.
    Gholamrezanezhad A; Muckle M; Ahmadzadehfar H; Biersack HJ; Ezziddin S
    Nuklearmedizin; 2010; 49(6):N69-70. PubMed ID: 21140034
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of Papillary Thyroid Carcinoma into Tall Cell Variant and TENIS Syndrome.
    Chakraborty A; Kane SV; Pawer Y; Basu S
    J Nucl Med Technol; 2016 Dec; 44(4):255-258. PubMed ID: 27834723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
    Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
    Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
    [No Abstract]   [Full Text] [Related]  

  • 8. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
    Bhargava P; Choi WS
    Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual case of well-differentiated papillary thyroid carcinoma lacking thyroglobulin expression while still concentrating radioiodine.
    Singh B; Bollmann R; Ahmadzadehfar H; Biersack HJ; Ezziddin S
    Br J Radiol; 2006 Sep; 79(945):e84-7. PubMed ID: 16940367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iodine scintigraphy of differentiated thyroid carcinoma].
    Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
    Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid carcinoma metastatic to pituitary.
    Sziklas JJ; Mathews J; Spencer RP; Rosenberg RJ; Ergin MT; Bower BF
    J Nucl Med; 1985 Sep; 26(9):1097. PubMed ID: 4032051
    [No Abstract]   [Full Text] [Related]  

  • 12. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
    Yagcloglu H; Ozalp E; Ibis E; Aras G
    Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
    [No Abstract]   [Full Text] [Related]  

  • 13. Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer?
    Campennì A; Pignata SA; Baldari S
    Endocrine; 2015 Nov; 50(2):516-8. PubMed ID: 25471282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retained esophagus uptake of iodine-131 in a patient with papillary thyroid carcinoma mimicking a mediastinal mass.
    Kurtaran A; Ozer S; Kienast O; Dobrozemsky G; Dudczak R
    Thyroid; 2003 Feb; 13(2):225. PubMed ID: 12699600
    [No Abstract]   [Full Text] [Related]  

  • 15. 68Ga-FAPI PET/CT in Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy.
    Fu H; Fu J; Huang J; Su X; Chen H
    Clin Nucl Med; 2021 May; 46(5):427-430. PubMed ID: 33661204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual extrathyroidal iodine accumulation in a post-ablative I-131 scan.
    McEwan LM; Fong W
    Australas Radiol; 2001 Nov; 45(4):512-3. PubMed ID: 11903188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
    Zakavi SR; Kakhki VD
    Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioiodine therapy for thyroid cancer depicted uterine leiomyoma.
    Hirata K; Shiga T; Kubota KC; Okamoto S; Kamibayashi T; Tamaki N
    Clin Nucl Med; 2009 Mar; 34(3):180-1. PubMed ID: 19352287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSO thyroid cancer guidelines questioned.
    Neal M
    Oncology (Williston Park); 1997 Dec; 11(12):1772, 1775. PubMed ID: 9436182
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual radioiodine uptake caused by metallic sutures in the skull in a patient with thyroid cancer.
    Modoni S; Martino G; Guerra M; Frusciante V
    Clin Nucl Med; 2000 Dec; 25(12):1053-4. PubMed ID: 11129153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.